GLP-1 Medications & Micronutrient Depletion

A clinical overview by Dr. Jefferson Vaughan, MD, FACS — Board-Certified Bariatric Surgeon, Jupiter Medical Center

GLP-1 receptor agonists — including semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) — represent a genuine breakthrough in metabolic medicine. They work by mimicking a natural gut hormone that slows gastric emptying, reduces appetite, and improves insulin sensitivity. The results in clinical practice have been remarkable: sustained weight loss, improved blood sugar control, and meaningful reductions in cardiovascular risk.

But there is a nutritional consequence that most prescribers and patients do not discuss at the outset: dramatic reductions in food intake create predictable micronutrient gaps.

Why food volume matters for nutrition

Most people on GLP-1 therapy quickly find that they can comfortably eat only a fraction of their previous food volume. This is the mechanism of action — and it is also the problem. Micronutrients are not stored in the body in large reserves the way fat is. Vitamins and minerals must be replenished daily through diet. When total food consumption drops by 40–60%, daily micronutrient intake drops proportionally — even when patients are making thoughtful food choices.

The nutrients most commonly depleted include:

• B vitamins — especially Thiamine (B1), B6, B12, and Folate. Thiamine deficiency in particular can develop within weeks of severely reduced intake and presents with neurological symptoms that are often misattributed to the medication itself.
• Iron — appetite suppression reduces red meat and fortified food consumption, accelerating iron depletion particularly in premenopausal women.
• Vitamin D and Calcium — reduced dairy and fortified food intake, combined with the fact that most adults are already insufficient, makes this a near-universal concern.
• Zinc and Magnesium — both are found primarily in foods that GLP-1 patients tend to eat less of: whole grains, legumes, meat, and nuts.
• Essential fatty acids — fat-soluble nutrient intake decreases significantly when overall food volume drops.

The clinical picture over time

Micronutrient deficiencies rarely announce themselves dramatically at first. Patients typically notice fatigue that they attribute to the diet, hair thinning at the three- to six-month mark, difficulty concentrating, or muscle cramps. By the time symptoms are obvious enough to prompt lab testing, significant depletion has already occurred. In our bariatric surgery practice, we have seen this pattern for decades — and GLP-1 therapy produces a nutritionally similar state to the early post-operative period after sleeve gastrectomy.

What this means for supplementation

The answer is straightforward: patients on GLP-1 therapy should be supplementing from the day they begin medication, not after symptoms appear. A comprehensive daily multivitamin formulated for high-potency B vitamin coverage — particularly near-therapeutic Thiamine dosing — along with targeted supplementation of iron, vitamin D3, and essential fatty acids provides the nutritional foundation that reduced food intake cannot.

Dr. V’s Daily Multi-Vitamin was developed with exactly this clinical scenario in mind: the nutrients your body needs daily, in the forms and at the doses that actually reach the bloodstream.

Shop Dr. V’s Daily Multi-Vitamin →

View all vitamins & supplements →

This content is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before beginning any supplement regimen. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.